BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Omics Empower Expands Spatial Transcriptomics Services With Xenium Platform In Hong Kong

Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In S...

February 16, 2026 | News

Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...

February 16, 2026 | News

Syngene Partners With Johns Hopkins To Accelerate Early Stage Drug Discovery

Syngene International, a global contract research, development, and manufacturing organization (CRDMO) announced a strategic collaboration with Johns Hopki...

February 13, 2026 | News

Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...

February 13, 2026 | News

WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...

February 13, 2026 | News

GCCL And Medicover Integrated Clinical Services Sign MOU To Strengthen Multinational Trial Delivery

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an internation...

February 12, 2026 | News

Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104

Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...

February 09, 2026 | News

PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly

Zonsen PepLib Biotech Inc. (“PepLib”) announced that it has entered a global research and development (R&D) collaboration and license agree...

February 06, 2026 | News

Everest Medicines Secures Exclusive Asia Pacific Rights To First In Class Dual Target SHPT Therapy MT1013

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturi...

February 06, 2026 | News

Insilico Medicine Receives $5 Million Milestone From Menarini Group After First Patient Dosed In Phase 1 Trial Of AI Designed Cancer Therapy

Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone paymen...

February 05, 2026 | News

SK bioscience Advances Early Clinical RSV Preventive Monoclonal Antibody Licensed From Gates Medical Research Institute

SK to advance novel early-clinical stage RSV preventive monoclonal antibody in-licensed from Gates Medical Research Institute Exclusive rights to commer...

February 05, 2026 | News

SanegeneBio Licenses RNAi Programme To Genentech In Global Deal Valued Up To USD 1.7 Billion

SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million up...

February 04, 2026 | News

GHIT Fund Commits JPY 1.39 Billion To Back Six R&D Programmes Across Malaria, Tuberculosis And Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projec...

February 04, 2026 | News

WuXi Biologics Partners With Vertex To Advance Trispecific T Cell Engager For Autoimmune Diseases

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has signed a license ...

February 04, 2026 | News

Stay Connected